ALLOPLEX BIOTHERAPEUTICS
Alloplex Biotherapeutics operates as a privately-owned Boston-based cellular therapeutics company. It has developed a non-engineered, tumor-agnostic cellular therapy platform with broad anti-tumor activity.
ALLOPLEX BIOTHERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.alloplexbio.com
Total Employee:
1+
Status:
Active
Total Funding:
21.2 M USD
Technology used in webpage:
Euro Cloudflare Hosting
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Investors List
HanAll Biopharma
HanAll Biopharma investment in Corporate Round - Alloplex Biotherapeutics
Daewoong Pharmaceutical
Daewoong Pharmaceutical investment in Corporate Round - Alloplex Biotherapeutics
Official Site Inspections
http://www.alloplexbio.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Alloplex Biotherapeutics"
About Alloplex - Alloplex Biotherapeutics
Alloplex is led by its scientific founder and CEO, Dr. Frank Borriello MD, PhD โ a Harvard-trained immunologist with over two decades pharmaceutical industry experience where he held positions of increasing responsibility, beginning as โฆSee details»
Alloplex Biotherapeutics - Crunchbase Company Profile โฆ
Alloplex Biotherapeutics operates as a privately-owned Boston-based cellular therapeutics company. It has developed a non-engineered, tumor-agnostic โฆSee details»
Cancer therapy Investment opportunities - Alloplex Biotherapeutics
Alloplex Biotherapeutics Inc - Org Chart, Teams, Culture & Jobs
View Alloplex Biotherapeutics Inc's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Alloplex Biotherapeutics - Overview, News & Similar ... - ZoomInfo
Alloplex Biotherapeutics Inc is a privately owned Boston-based cellular therapeutics company with headquarters and laboratories located in Woburn M A, USA; and a wholly owned subsidiary โฆSee details»
Alloplex Biotherapeutics Company Profile | Management and
Alloplex Biotherapeutics Profile and History. Alloplex Biotherapeutics Inc is a privately owned Boston-based cellular therapeutics company with headquarters and laboratories located in โฆSee details»
Frank Borriello - advancedtherapiesweek.phacilitate.com
Dec 1, 2021 Since then โ as Scientific Founder and CEO of Alloplex โ Dr. Borriello has led the organization through research, fundraising and business development, to Phase 1 clinical trials for SUPLEXA therapy which โฆSee details»
Alloplex Biotherapeutics Inc - LinkedIn
Alloplex Biotherapeutics is dedicated to exploring the higher order combinatorial space of immunomodulators to develop an effective anti-tumor vaccine. This approach is applicable to all tumor ...See details»
Alloplex Biotherapeutics, Inc - VentureRadar
Website: https://www.alloplexbio.com/ Develops a unique, non-engineered cellular therapy platform with extensive anti-tumor capabilities, applicable across various ...See details»
Alloplex Biotherapeutics, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Alloplex Biotherapeutics, LLC of Winchester, MA. Get the latest business insights from Dun & Bradstreet.See details»
A novel tumor-agnostic cellular therapy platform
Scientific summary. Since 2016, Alloplex has engaged in extensive research to refine and develop the original concept conceived by Frank Borriello, MD, PhD (U.S. Patent 10,731,128).Alloplex โฆSee details»
Alloplex Biotherapeutics - Craft
Alloplex Biotherapeutics is a company that specializes in the development of cellular therapies. It provides SUPLEXA cells, a peripheral blood mononuclear cell (PBMC)-derived multicellular โฆSee details»
The CDI Experts: Renowned Scientist Korngold, at Retirement โฆ
Dec 15, 2021 Led by Scientific Founder and CEO, Dr. Frank Borriello, M.D., Ph.D, the organization has developed an autologous cellular therapy derived from peripheral blood โฆSee details»
Alloplex Biotherapeutics, Inc. (Alloplex Biotherapeutics, Inc.) - ่ฏ็ฉ โฆ
2546 Background: SUPLEXA therapeutic cells are the initial autologous and non-engineered candidate to emerge from the novel ENLIST cells training platform. Manufacturing is robust, โฆSee details»
Alloplex set to validate crucial immunotherapy hypothesis and โฆ
Mar 27, 2024 Email: [email protected] Attn: Lesley White, Alloplex Australia. For media requests on deadline during USA Eastern hours, please call: +1-781-281-2013. For Investors. โฆSee details»
Frank Borriello - Phacilitate
Since then โ as Scientific Founder and CEO of Alloplex โ Dr. Borriello has led the organization through research, fundraising and business development, to Phase 1 clinical trials for โฆSee details»
Media and Press - Alloplex Biotherapeutics
Email: [email protected] Attn: Lesley White, Alloplex Australia. For media requests on deadline during USA Eastern hours, please call: +1-781-281-2013. For Investors. Executive โฆSee details»
Alloplexโs Suplexa reawakens immune cells to fight cancer
Nov 26, 2024 When it comes to cell therapy, Alloplex Biotherapeutics Inc. CEO Frank Borriello said he believes that autologous, personalized therapy is the only thing that makes sense. โฆSee details»
Alloplex to present emerging data from SUPLEXA-101 trial at โฆ
Apr 19, 2023 Media Contact. To request interviews, high res images or other materials, media are asked to: Email: [email protected] Attn: Lesley White, Alloplex Australia. For media โฆSee details»